Blue Horseshoe Stocks: A Special Report


PositiveID Corp. PSID

As a special point of focus today, we’re going to be talking about PSID, and the reasons for our attraction to this stock are numerous. From fundamentals to technicals, PSID has the look of a high potential play, so this morning we’ll outline what we feel are some of the highlights to provide our readers with a good jumping-off point from which to start their own due diligence. Ā 

__________

One of the first things that strikes us with regard to PSID is the frequency and substance of recent press releases. The company appears to be taking a proactive and multifaceted approach to its growth including two complementary acquisitions, as well as the announcement of other updates regarding its existing technologies (pictured below).

Prior to the end of 2015, PSID‘s two primary products under development were the Firefly Dx handheld point-of-need diagnostic device, and the M-BAND bio-threat detector.

The M-BAND is serious business, detecting potentially harmful biological agents in high-traffic public locales such as airports and subway terminals. It was developed with funds attained via the Department of Homeland Securities next-gen BioWatch program, and PSID has an exclusive licensing and manufacturing agreement with the Boeing Company.

The company’s working prototype Firefly Dx has proven successful at detecting influenza, MRSA, E.coli, and several other harmful pathogens without the help of a brick-and-mortar lab, and according to the company’s projections a fully field-testable unit will be functional later this year. When perfected, it will provide a highly synergistic complement to PSID’s other recent acquisitions.

The first of which was in the beginning of December, when the company acquired Thermomedics, Inc. and its flagship product, the FDA-cleared CaregiverĀ® non-contact infrared thermometer. (>>View PR)

Just prior to the new year PSID announced another exciting acquisition that has the ability to take its business to the next level, as it ties the company’s other technologies together. E-N-G Mobile Systems has been in business for 25 years, and has averaged $4M in revenue annually with its mobile laboratories. With the added facility of ambulatory lab systems, PositiveID’s ability and effectiveness in addressing the ever-growing necessity for rapid biological threat detection in the field should be stronger than ever. (>>View PR)
__________

In addition to the expansion of its portfolio, PSID has also been making fundamental strides, as recent filings clearly indicate. The 2015 fiscal year brought increased revenues and cash flow, and the recent acquisitions should serve to bolster those figures even further in 2016. (>>View Filings)

We also want to look at the PSID chart, which in and of itself would be reason enough for us to track this stock. Over the past three consecutive sessions PSID has recorded higher highs and higher lows, building support off of its recently established 52-week low. This is exactly the type of ripening bounce-play setup that we search for on a daily basis.

As is evident on the snapshot below, the stock also has a documented history of making rapid moves to the upside. We could be catching this play at a prime moment for a continued recovery, so it will be among our top interests in sessions to come.

__________

RECENT PR LINKS

___________

For More Information on PositiveID visit:
http://www.psidcorp.com